Ticker League

Vertex Pharmaceuticals (VRTX) Cash Flow Waterfall

Trace Vertex Pharmaceuticals's operating cash flow down to free cash flow, then see where FCF goes — capex, buybacks, dividends, and debt repayment.

TTM

Operating CF

$4.24B

Capex

-$530M

Free Cash Flow

$3.71B

FCF Margin

+87.5%

Cash flow waterfall for Vertex Pharmaceuticals (VRTX) — TTM through Q1 2026

Free cash flow: $3.71B

Cash flow breakdown for Vertex Pharmaceuticals (VRTX) — TTM through Q1 2026

  • Operating Cash Flow$4.24B
  • Capital Expenditure-$530M
  • Free Cash Flow$3.71B
  • Other Investing-$791M
  • Share Buybacks-$1.93B
  • Other Financing & FX-$169M
  • Net Cash Increase$820M
Want to see what drove the FCF change?Free Cash Flow Bridge

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation